Article Information
History
- December 2, 2020.
Article Versions
- Version 1 (December 2, 2020 - 08:14).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
REVISION SUMMARY
Supplemental file updated
Author Information
- Jennifer L. Guthrie1,
- Sarah Teatero1,
- Sandra Zittermann1,
- Yao Chen1,
- Ashleigh Sullivan2,
- Heather Rilkoff1,
- Esha Joshi1,
- Karthikeyan Sivaraman1,
- Richard de Borja3,
- Yogi Sundaravadanam3,
- Michael Laszloffy3,
- Lawrence Heisler3,
- Vanessa G. Allen1,4,
- Jared T. Simpson3,5 and
- Nahuel Fittipaldi1,4,6,*
- 1Public Health Ontario, Toronto, Ontario, Canada
- 2Public Health Agency of Canada, Ottawa, Ontario, Canada
- 3Ontario Institute for Cancer Research, Toronto, Ontario, Canada
- 4Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada
- 5Department of Computer Science, University of Toronto, Toronto, Canada
- 6Department of Cell and Systems Biology, University of Toronto, Toronto, Ontario, Canada
- ↵*Corresponding Author:
Nahuel Fittipaldi, PhD, Public Health Ontario,Toronto, ON M5G 1M1, Canada. Phone: (647) 792-3429. e-mail: Nahuel.Fittipaldi{at}oahpp.ca
Posted December 02, 2020.
Detection of the Novel SARS-CoV-2 European Lineage B.1.177 in Ontario, Canada
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos